Scientists track cancer stem cell marker in pancreatic tumors
NCT ID NCT01580241
First seen Apr 05, 2026 · Last updated May 12, 2026 · Updated 7 times
Summary
This study examines a protein called DCAMKL-1, which may be a stem cell marker in pancreatic cancer. Researchers will measure its levels in 60 patients before and after standard treatment to see how it changes. The goal is to learn more about the disease, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stephensen Cancer Center
Oklahoma City, Oklahoma, 73104, United States
Conditions
Explore the condition pages connected to this study.